Acrivon Therapeutics, Inc. · NASDAQ:ACRV

Miller Mary sold 573 Acrivon Therapeutics, Inc. shares (Form 4)

Traded Jul 21, 2026 · Filed Jul 23, 2026

On Jul 21, 2026, Miller Mary (Chief Legal Officer) sold 573 Acrivon Therapeutics, Inc. shares at US$1.76 for US$1,008, leaving 82,194 shares. Filed Jul 23, 2026 (Form 4).

Sold
573 shares
Price
US$1.76
Value
US$1,008
Holding after
82,194 shares
Trading plan
No
Role
Chief Legal Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jul 21, 2026Common StockSale573US$1.7682,194Direct

Source

View original at SEC

Related